Expansion of warning statement may be considered after submission of first year PSUR data: CDSCO panel on AstraZeneca's anticancer drug Dr. Divya Colin25 Jun 2024 10:28 PM ISTNew Delhi: Noting that Tremelimumab Concentrate for Solution for infusion 20 mg/ml is not yet launched in the Indian market, the Subject Expert...
AstraZeneca Truqap, Faslodex combo approved in EU for advanced ER-positive breast cancer Ruchika Sharma21 Jun 2024 10:00 AM ISTCambridge: AstraZeneca has announced that Truqap (capivasertib) in combination with Faslodex (fulvestrant) has been approved in the...
AstraZeneca Imfinzi plus chemotherapy gets USFDA nod for mismatch repair deficient advanced or recurrent endometrial cancer Ruchika Sharma17 Jun 2024 11:30 AM ISTCambridge: AstraZeneca has announced that Imfinzi (durvalumab) in combination with carboplatin and paclitaxel followed by Imfinzi monotherapy has...
AstraZeneca Farxiga gets USFDA nod for paediatric type 2 diabetes Ruchika Sharma14 Jun 2024 11:30 AM ISTCambridge: AstraZeneca has announced that the US Food and Drug Administration (FDA) has approved Farxiga (dapagliflozin) for the improvement of...
AstraZeneca Tagrisso gets USFDA priority review for unresectable, Stage III EGFR-mutated lung cancer Ruchika Sharma11 Jun 2024 11:39 AM ISTAstraZeneca's supplemental New Drug Application (sNDA) for TAGRISSO (osimertinib) has been accepted and granted Priority Review in the US for the...
AstraZeneca Tagrisso, chemotherapy recommended for approval in EU by CHMP for EGFR-mutated advanced lung cancer Ruchika Sharma5 Jun 2024 2:00 PM ISTCambridge: AstraZeneca's Tagrisso (osimertinib) with the addition of pemetrexed and platinum-based chemotherapy has been recommended for...
AstraZeneca concludes acquisition of Fusion Pharma Ruchika Sharma5 Jun 2024 10:15 AM ISTCambridge: AstraZeneca has announced the successful completion of the acquisition of Fusion Pharmaceuticals Inc., a clinical-stage...
Oral PCSK9 inhibitor, AZD0780 demonstrates significant Reduction of LDL-C in Hypercholesterolemia patients in phase 1 trial Dr. Kamal Kant Kohli5 Jun 2024 10:00 AM ISTPositive results from a Phase I trial of AZD0780, an oral small molecule PCSK9 inhibitor administered on top of statin treatment, were presented at...
AstraZeneca Pharma India Gets CDSCO Panel Nod To Import, Market Eculizumab for Atypical hemolytic uremic syndrome Dr. Divya Colin27 May 2024 6:00 PM ISTNew Delhi: The drug major AstraZeneca Pharma India has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug...
Discontinue Olaparib Tablets Marketing For Specific Cancers: CDSCO Dr. Divya Colin23 May 2024 6:00 PM ISTNew Delhi: In a recent notification, the Central Drugs Standard Control Organisation (CDSCO) has directed all manufacturers of the anticancer...
ICMR distances itself from BHU Covaxin study, calls it poorly designed Anshika Mishra21 May 2024 5:42 PM ISTThe apex research regulator, the Indian Council of Medical Research (ICMR) has distanced itself from the study, published by the Banaras Hindu...
Health Bulletin 21/ May/ 2024 Anshika Mishra21 May 2024 5:25 PM ISTHere are the health stories for the day:Heatwaves increase hospitalization risk for children with asthma, study findsA recent study by the University...
